Keywords: |
review; nuclear magnetic resonance imaging; positron emission tomography; methodology; sensitivity and specificity; neoplasm; neoplasms; animal; metabolism; animals; imatinib; computer assisted tomography; biological model; models, biological; image analysis; protein protein interaction; pathology; diagnostic imaging; pyrimidines; protein p53; ultrasound; time; time factors; imaging system; gene expression regulation; quantitative analysis; computer assisted emission tomography; gene therapy; reporter gene; tumor suppressor protein p53; genes, reporter; piperazines; piperazine derivative; pyrimidine derivative; genetic techniques; genetic procedures; tomography, emission-computed; humans; human; priority journal
|